Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. 1997

T G Markees, and N E Phillips, and R J Noelle, and L D Shultz, and J P Mordes, and D L Greiner, and A A Rossini
Diabetes Division, University of Massachusetts Medical School, Biotech 2, Worcester 01605, USA.

Combined treatment with antibody against CD40 ligand and one transfusion of donor splenocytes prolonged survival of fully mismatched BALB/c skin allografts on C57BL/6 recipients, with approximately 20% of grafts surviving > 100 days. In vitro alloresponsiveness in treated animals was reduced in the immediate post-transplantation period, but by day 100 was increased despite the presence of a successful allograft. The presence of alloreactivity on day 100 was confirmed in vivo by adoptive transfer, which suggests that our protocol had induced either a state of "split tolerance" or "graft accommodation." Mice with skin grafts that had survived for > or = 100 days revealed no evidence of lymphoid chimerism. Treatment with donor splenocytes and antibody against CD40 ligand permits long-term survival of highly antigenic donor skin allografts despite the presence of functionally intact alloreactive lymphocytes.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002678 Chimera An individual that contains cell populations derived from different zygotes. Hybrids,Chimeras,Hybrid
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections

Related Publications

T G Markees, and N E Phillips, and R J Noelle, and L D Shultz, and J P Mordes, and D L Greiner, and A A Rossini
October 1995, Proceedings of the National Academy of Sciences of the United States of America,
T G Markees, and N E Phillips, and R J Noelle, and L D Shultz, and J P Mordes, and D L Greiner, and A A Rossini
January 2018, The Journal of surgical research,
T G Markees, and N E Phillips, and R J Noelle, and L D Shultz, and J P Mordes, and D L Greiner, and A A Rossini
January 1970, Clinical and experimental immunology,
T G Markees, and N E Phillips, and R J Noelle, and L D Shultz, and J P Mordes, and D L Greiner, and A A Rossini
October 1972, Transplantation,
T G Markees, and N E Phillips, and R J Noelle, and L D Shultz, and J P Mordes, and D L Greiner, and A A Rossini
January 1975, Transplantation,
T G Markees, and N E Phillips, and R J Noelle, and L D Shultz, and J P Mordes, and D L Greiner, and A A Rossini
October 2001, Plastic and reconstructive surgery,
T G Markees, and N E Phillips, and R J Noelle, and L D Shultz, and J P Mordes, and D L Greiner, and A A Rossini
June 1969, The Keio journal of medicine,
T G Markees, and N E Phillips, and R J Noelle, and L D Shultz, and J P Mordes, and D L Greiner, and A A Rossini
June 1980, The Journal of experimental zoology,
T G Markees, and N E Phillips, and R J Noelle, and L D Shultz, and J P Mordes, and D L Greiner, and A A Rossini
February 2008, Experimental & molecular medicine,
T G Markees, and N E Phillips, and R J Noelle, and L D Shultz, and J P Mordes, and D L Greiner, and A A Rossini
April 2000, Transplantation,
Copied contents to your clipboard!